Hi All,
I too have been following this thread with great interest. I could have sworn that I read this is a small patient group - 6-20 patients and in Canada. What are the possibilities of entering a clinical trial in a foreign country? Also, isn't phase 1 typically about determining levels of toxicity more than therapeutic benefit which is more of a phase 2 thing. More Brian can expound a little on this.


Gary Allsebrook
***********************************
Dx 11/22/02, SCC, 6 x 3 cm Polypoid tumor, rt tonsil, Stage III/IVA, T3N0M0 G1/2
Tx 1/28/03 - 3/19/03, Cisplatin ct x2, IMRT, bilateral, with boost, x35(69.96Gy)
________________________________________________________
"You are a mist that appears for a little while and then vanishes" (James 4:14 NIV)